Leg ulcer treatments: a critical review (Part 1).

N. Cullum

DOI: https://doi.org/10.7748/ns.9.1.29.s42

1994-09-28

Nursing Standard

Abstract:

What problem does this paper attempt to address?

Social Determinants of Health and US Health Care Expenditures by Insurer

Giridhar Mohan,Darrell J Gaskin

DOI: https://doi.org/10.1001/jamanetworkopen.2024.40467

2024-10-01

Abstract:Importance: US health expenditures have been growing at an unsustainable rate, while health inequities and poor outcomes persist. Targeting social determinants of health (SDOH) may contribute to identifying and controlling health care expenditures. Objective: To determine whether SDOH are associated with US health care expenditures by Medicare, Medicaid, and private insurers. Design, setting, and participants: Cross-sectional study of adults, representing the US civilian, noninstitutionalized population with Medicare, Medicaid, or private coverage, from the 2021 Medical Expenditure Panel SDOH Survey. Data analysis was conducted from October 2023 to April 2024. Exposure: SDOH as individual-level, health-related social needs categorized by Healthy People 2030 domains: (1) educational access and quality, (2) health care access and quality, (3) neighborhood and built environment,(4) economic stability, and (5) social and community context. Main outcomes and measures: The primary outcome was health care expenditures (US dollars) by Medicare, Medicaid, and private insurers. A 2-part econometric model (probit regression model and generalized linear model with gamma distribution) was used. Results: Among the 14 918 insured adults in the analytic sample (mean [SD] age, 52.5 [17.9] years; 8471 female [56.8%]), the majority had middle to high family income (10 524 participants [70.5%]) and were privately insured (10 227 participants [68.5%]). Annual median (IQR) expenditure was $1648 ($389-$7126) for Medicaid, $3643 ($1321-$10 519) for Medicare, and $1369 ($456-$4078) for private insurers. Educational attainment and social isolation were associated with Medicaid expenditures. Medicaid beneficiaries with a high school diploma or general educational development certificate had on average (mean difference) $2245.39 lower annual Medicaid expenditures (95% CI, -$3700.97 to -$789.80) compared with beneficiaries with less than high school attainment. Compared with those who never felt isolated, Medicaid beneficiaries who often felt isolated had on average $2706.94 (95% CI, $1339.06-$4074.82) higher annual Medicaid expenditures. Health care access, built environment, and economic stability were associated with Medicare expenditures. Medicare beneficiaries living in neighborhoods with lower availability of parks had on average $5959.27 (95% CI, $1679.99 to $10 238.55) higher annual Medicare expenditures. Medicare beneficiaries who were very confident in covering unexpected expenses had on average $3743.98 lower annual Medicare expenditures (95% CI, -$6500.68 to -$987.28) compared with those who were not confident. Medical discrimination and economic stability were associated with private expenditures. Private insurance beneficiaries who experienced medical discrimination had on average $2599.93 (95% CI, $863.71-$4336.15) higher annual private expenditures compared with those who did not. Private beneficiaries who were contacted by debt collections in the past year had on average $2033.34 (95% CI, $896.82 to $3169.86) higher annual private expenditures compared with those who were not contacted. Conclusions and relevance: In this cross-sectional study of 14 918 insured adults, individual-level SDOH were significantly associated with US health care expenditures by Medicare, Medicaid, and private insurers. These findings may inform health insurers and policymakers to incorporate SDOH in their decision-making practices to identify and control health care expenditures, advancing health equity.
Beyond average spending: distributional and seasonal commercial insurance trends, 2012-2021

Erin L Duffy,Sarah Green,Samantha Randall,Erin Trish

DOI: https://doi.org/10.37765/ajmc.2024.89600

Abstract:Objectives: The annual mean spending measures typically used to study longitudinal trends mask distributional and seasonal variation that is relevant to patients' perceptions of health care affordability and, in turn, provider collections. This study describes shifts in the distribution and seasonality of plan and patient out-of-pocket spending from 2012 through 2021. Study design: Analysis of multipayer commercial claims data. Methods: Medical spending per enrollee was calculated by summing inpatient, outpatient, and professional services, which comprised plan payments and out-of-pocket payments (deductible, coinsurance, co-payment). To account for the long right tail of the spending distribution, enrollees were stratified by their decile of annual medical spending, and annual mean spending estimates were calculated overall and by decile. Mean spending estimates were also calculated by quarter-year. Results: Inflation-adjusted medical spending grew most quickly among the highest decile of spenders, without proportional growth in their out-of-pocket expenses. Out-of-pocket spending increased for the majority of enrollees in our sample prior to the COVID-19 pandemic, in real dollars and as a share of total medical spending. Out-of-pocket spending was increasingly concentrated in the early months of the calendar year, driven by deductible spending, and was lower in 2020 and 2021, plausibly due to policies limiting cost sharing for COVID-19-related services. Conclusions: Insurance is working well to protect the highest spenders at the cost of reduced insurance generosity among spenders elsewhere in the distribution. The increasing cross-subsidization among enrollees through cost-sharing design-vs premiums-is a trend to watch among rising public concerns about underinsurance and medical debt.
Reducing administrative costs in US health care: Assessing single payer and its alternatives

David Scheinker,Barak D Richman,Arnold Milstein,Kevin A Schulman

DOI: https://doi.org/10.1111/1475-6773.13649

Abstract:Objective: Excess administrative costs in the US health care system are routinely referenced as a justification for comprehensive reform. While there is agreement that these costs are too high, there is little understanding of what generates administrative costs and what policy options might mitigate them. Data sources: Literature review and national utilization and expenditure data. Study design: We developed a simulation model of physician billing and insurance-related (BIR) costs to estimate how certain policy reforms would generate savings. Our model is based on structural elements of the payment process in the United States and considers each provider's number of health plan contracts, the number of features in each health plan, the clinical and nonclinical processes required to submit a bill for payment, and the compliance costs associated with medical billing. Data extraction: For several types of visits, we estimated fixed and variable costs of the billing process. We used the model to estimate the BIR costs at a national level under a variety of policy scenarios, including variations of a single payer "Medicare-for-All" model that extends fee-for-service Medicare to the entire population and policy efforts to reduce administrative costs in a multi-payer model. We conducted sensitivity analyses of a wide variety of model parameters. Principal findings: Our model estimates that national BIR costs are reduced between 33% and 53% in Medicare-for-All style single-payer models and between 27% and 63% in various multi-payer models. Under a wide range of assumptions and sensitivity analyses, standardizing contracts generates larger savings with less variance than savings from single-payer strategies. Conclusion: Although moving toward a single-payer system will reduce BIR costs, certain reforms to payer-provider contracts could generate at least as many administrative cost savings without radically reforming the entire health system. BIR costs can be meaningfully reduced without abandoning a multi-payer system.
The Effects on Hospital Utilization of the 1966 and 2014 Health Insurance Coverage Expansions in the United States

Adam Gaffney,Danny McCormick,David H Bor,Anna Goldman,Steffie Woolhandler,David U Himmelstein,David H. Bor,David U. Himmelstein

DOI: https://doi.org/10.7326/m18-2806

IF: 39.2

2019-07-23

Annals of Internal Medicine

Abstract:<section class="abstract"><section class="sec"><span class="subhead-body">Background:</span><p>Persons with comprehensive health insurance use more hospital care than those who are uninsured or have high-deductible plans. Consequently, analysts generally assume that expanding coverage will increase society-wide use of inpatient services. However, a limited supply of beds might constrain this growth.</p></section><section class="sec"><span class="subhead-body">Objective:</span><p>To determine how the implementations of Medicare and Medicaid (1966) and the Patient Protection and Affordable Care Act (ACA) (2014) affected hospital use.</p></section><section class="sec"><span class="subhead-body">Design:</span><p>Repeated cross-sectional study.</p></section><section class="sec"><span class="subhead-body">Setting:</span><p>Nationally representative surveys.</p></section><section class="sec"><span class="subhead-body">Participants:</span><p>Respondents to the National Health Interview Survey (1962 to 1970) and Medical Expenditure Panel Survey (2008 to 2015).</p></section><section class="sec"><span class="subhead-body">Measurements:</span><p>Mean hospital discharges and days were measured, both society-wide and among subgroups defined by income, age, and health status. Changes between preexpansion and postexpansion periods were analyzed using multivariable negative binomial regression.</p></section><section class="sec"><span class="subhead-body">Results:</span><p>Overall hospital discharges averaged 12.8 per 100 persons in the 3 years before implementation of Medicare and Medicaid and 12.7 per 100 persons in the 4 years after (adjusted difference, 0.2 discharges [95% CI, −0.1 to 0.4 discharges] per 100 persons; <em>P</em> = 0.26). Hospital days did not change in the first 2 years after implementation but increased later. Effects differed by subpopulation: Adjusted discharges increased by 2.4 (CI, 1.7 to 3.1) per 100 persons among elderly compared with nonelderly persons (<em>P</em> < 0.001) and also increased among those with low incomes compared with high-income populations. For younger and higher-income persons, use decreased. Similarly, after the ACA's implementation, overall hospital use did not change: Society-wide rates of discharge were 9.4 per 100 persons before the ACA and 9.0 per 100 persons after the ACA (adjusted difference, −0.6 discharges [CI, −1.3 to 0.2 discharges] per 100 persons; <em>P</em> = 0.133), and hospital days were also stable. Trends differed for some subgroups, and rates decreased significantly in unadjusted (but not adjusted) analyses among persons reporting good or better health status and increased nonsignificantly among those in worse health.</p></section><section class="sec"><span class="subhead-body">Limitation:</span><p>Data sources relied on participant recall, surveys excluded institutionalized persons, and follow-up after the ACA was limited.</p></section><section class="sec"><span class="subhead-body">Conclusion:</span><p>Past coverage expansions were associated with little or no change in society-wide hospital use; increases in groups who gained coverage were offset by reductions among others, suggesting that bed supply limited increases in use. Reducing coverage may merely shift care toward wealthier and healthier persons. Conversely, universal coverage is unlikely to cause a surge in hospital use if growth in hospital capacity is carefully constrained.</p></section><section class="sec"><p>None.</p></section></section>

medicine, general & internal
Impact of Business Operations and Policies on Healthcare Costs

Krish Kawle,Matt DeSantis,Jeremy Cimino

DOI: https://doi.org/10.47611/jsrhs.v13i1.6011

2024-02-29

Journal of Student Research

Abstract:It is no surprise that the United States has a problem managing its healthcare costs. To get insurance to cover medical costs, people have to stay in-network, pay their premiums, yearly fees, meet their deductible–which is the maximum out-of-pocket cost–pay a copay–a fee for a physician visit or prescription refill–and finally pay their co-insurance: the percentage of a medical bill the customer has to pay. The United States has access to some of the best medicine in the world with state of the art MRIs, which much research and development happening in the United States, and “the U.S. has four times the number of MRIs per capita as Canada, and three times the number of cardiac surgeons” (Cutler, 2020). There are many reasons as to why healthcare costs are so high in this country, one major reason is inflated health administration costs. This paper examines what is the cause for high health administration costs, and aims to find policies that could be implemented to lower these costs.
Health care administration in the United States and Canada: micromanagement, macro costs

Steffie Woolhandler,Terry Campbell,David U Himmelstein

DOI: https://doi.org/10.2190/MJJW-GA0V-78KT-9RGX

Abstract:A decade ago, U.S. health administration costs greatly exceeded Canada's. Have the computerization of billing and the adoption of a more business-like approach to care cut administrative costs? For the United States and Canada, the authors calculated the 1999 administrative costs of health insurers, employers' health benefit programs, hospitals, practitioners' offices, nursing homes, and home care agencies; they analyzed published data, surveys of physicians, employment data, and detailed cost reports filed by hospitals, nursing homes, and home care agencies; they used census surveys to explore time trends in administrative employment in health care settings. Health administration costs totaled at least dollar 294.3 billion, dollar 1,059 per capita, in the United States vs. dollar 9.4 billion, dollar 307 per capita, in Canada. After exclusions, health administration accounted for 31.0 percent of U.S. health expenditures vs. 16.7 percent of Canadian. Canada's national health insurance program had an overhead of 1.3 percent, but overhead among Canada's private insurers was higher than in the U.S.: 13.2 vs. 11.7 percent. Providers' administrative costs were far lower in Canada. Between 1969 and 1999 administrative workers' share of the U.S. health labor force grew from 18.2 to 27.3 percent; in Canada it grew from 16.0 percent in 1971 to 19.1 percent in 1996. Reducing U.S. administrative costs to Canadian levels would save at least dollar 209 billion annually, enough to fund universal coverage.
Demand Management: Enabling Patients to Use Medical Care Appropriately

Donald M. Vickery,Wendy D. Lynch

DOI: https://doi.org/10.1097/00043764-199505000-00001

1995-05-01

Journal of Occupational and Environmental Medicine

Abstract:A rationale is presented for considering demand management as well as supply management (managed care) in the current debate on health care reform. Demand management is the support of individuals so that they may make rational health and medical decisions based on a consideration of benefits and risks. The concept of demand for medical services is examined within a theoretical framework of four components: morbidity, perceived need, patient preference, and nonhealth motives. Two components, perceived need and patient preference, are suggested to offer considerable potential for making utilization more appropriate and reducing costs. Current demand services and potential hazards related to their continued expansion are discussed.

public, environmental & occupational health
Spending on and Use of Clinician-Administered Drugs in Medicare

Megan F Hyland,Rebecca M Sachs,Lara Robillard,Tamara B Hayford,Ge Bai

DOI: https://doi.org/10.1001/jamahealthforum.2023.2941

2023-09-01

JAMA Health Forum

Abstract:Importance: Medicare Part B drug expenditures have increased in recent years. This trend is likely to persist given the increased use and availability of biologics. Objectives: To assess the extent to which Medicare Part B spending growth was associated with changes in price vs quantity, and how these trends interacted with entry of new drugs into the marketplace. Design, setting, and participants: This cross-sectional study quantified the degree of spending concentration and the association between price and use of Part B drugs among fee-for-service Medicare beneficiaries. Data on use and spending for separately payable Part B drugs were included. Source data were aggregated to the drug-year level and reported from 2016 to 2020. Descriptive decomposition and index analyses quantified the relative association of price and use changes separately for existing single-source drugs, existing drugs that faced competition, and new drugs that entered the market. Data analysis was performed from June to December 2022. Main outcomes and measures: Part B drug spending by the fee-for-service Medicare program and beneficiaries, as well as use, defined as dosage units and beneficiaries using the drugs. Results: The study included 535 unique Part B drug products. From 2016 to 2020, 15 or fewer products comprised half of all Part B drug expenditures. The set of 7 drugs that comprised the top 25% of spending was very consistent over time, and all were biologics. Part B drug products that cost $1.85 or less per administration accounted for more than half of the doses administered in 2020. Spending on Part B drugs increased by $15 billion from 2016 to 2020. The entry of new, nonbiosimilar drugs during this period accounted for $12 billion of this increased spending (80%), while shifts in use and price increases among existing single-source brand drugs accounted for the remaining increase in spending. Part B spending decreased among the subset of existing drugs facing generic or biosimilar competition. Among single-source drugs on the market in 2016, the index that varied dosage units exceeded the index that varied price in all years, confirming that changes in use were associated more with spending growth for those drugs. Conclusions and relevance: In this cross-sectional study of Medicare Part B drug expenditures, spending was found to be concentrated among a small number of drugs. The entry of new products was a key factor associated with recent increases in Part B drug spending. These findings suggest that policies targeting top-selling drugs may have greater potential to curb Part B drug spending than those targeting price growth.
A simple screening method for detecting isovalerylglycine in urine patients with isovaleric acidemia.

T. Ando,W. Nyhan

DOI: https://doi.org/10.1093/CLINCHEM/16.5.420

IF: 12.114

1970-05-01

Clinical Chemistry

Abstract:
Policy Steps in the Federal Budget and Health Care to Achieve Sustainable Fiscal Conditions in the U.S.

Mark J. Warshawsky,John Mantus,Gaobo Pang

DOI: https://doi.org/10.1016/j.jpolmod.2024.05.012

IF: 2.727

2024-06-07

Journal of Policy Modeling

Abstract:Health care spending has grown significantly in the US, and is a major cause of rising federal deficits. Official projections find that low economic growth and aging of the population will lead to a modest continuation of this situation, but they miss that labor shortages have a particular impact on inefficient sectors, raising the cost of health care. We develop a unified macroeconomic model to address this shortcoming, with key variables—particularly in the health care sector and interest rates—endogenously determined. We find that the current fiscal trajectory of the US is unsustainable, with future deficits and debt well beyond both historical norms and official projections. Policy steps, focusing on reducing health care spending, increasing capital, and fiscal retrenchment, can lead to sustainable fiscal conditions and raise living standards that will otherwise fall.

economics
Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits

Brystana G Kaufman,Kelley A Jones,Melissa A Greiner,Abhigya Giri,Lucas Stewart,Amanda He,Amy G Clark,Donald H Taylor Jr,M Kate Bundorf,Rebecca G Whitaker,Courtney H Van Houtven,Aparna Higgins

DOI: https://doi.org/10.1001/jamahealthforum.2023.0973

2023-05-05

JAMA Health Forum

Abstract:Importance: Beneficiaries dual eligible for Medicare and Medicaid account for a disproportionate share of expenditures due to their complex care needs. Lack of coordination between payment programs creates misaligned incentives, resulting in higher costs, fragmented care, and poor health outcomes. Objective: To inform the design of integrated programs by describing the health care use and spending for need-based subgroups in North Carolina's full benefit, dual-eligible population. Design, setting, and participants: This cross-sectional study using Medicare and North Carolina Medicaid 100% claims data (2014-2017) linked at the individual level included Medicare beneficiaries with full North Carolina Medicaid benefits. Data were analyzed between 2021 and 2022. Exposure: Need-based subgroups: community well, home- and community-based services (HCBS) users, nursing home (NH) residents, and intensive behavioral health (BH) users. Measures: Medicare and Medicaid utilization and spending per person-year (PPY). Results: The cohort (n = 333 240) comprised subgroups of community well (64.1%, n = 213 667), HCBS users (15.0%, n = 50 095), BH users (15.2%, n = 50 509), and NH residents (7.5%, n = 24 927). Overall, 61.1% reported female sex. The most common racial identities included Asian (1.8%), Black (36.1%), and White (58.7%). Combined spending for Medicare and Medicaid was $26 874 PPY, and the funding of care was split evenly between Medicare and Medicaid. Among need-based subgroups, combined spending was lowest among community well at $19 734 PPY with the lowest portion (38.5%) of spending contributed by Medicaid ($7605). Among NH residents, overall spending ($68 359) was highest, and the highest portion of spending contributed by Medicaid (70.1%). Key components of spending among HCBS users' combined total of $40 069 PPY were clinician services on carrier claims ($14 523) and outpatient facility services ($9012). Conclusions and relevance: Federal and state policy makers and administrators are developing strategies to integrate Medicare- and Medicaid-funded health care services to provide better care to the people enrolled in both programs. Substantial use of both Medicare- and Medicaid-funded services was found across all need-based subgroups, and the services contributing a high proportion of the total spending differed across subgroups. The diversity of health care use suggests a tailored approach to integration strategies with comprehensive set benefits that comprises Medicare and Medicaid services, including long-term services and supports, BH, palliative care, and social services.
Health Spending In The United States And The Rest Of The Industrialized World

Gerard F. Anderson,Peter S. Hussey,Bianca K. Frogner,Hugh R. Waters

DOI: https://doi.org/10.1377/hlthaff.24.4.903

2005-07-01

Health Affairs

Abstract:U.S. citizens spent $5,267 per capita for health care in 2002--53 percent more than any other country. Two possible reasons for the differential are supply constraints that create waiting lists in other countries and the level of malpractice litigation and defensive medicine in the United States. Services that typically have queues in other countries account for only 3 percent of U.S. health spending. The cost of defending U.S. malpractice claims is estimated at $6.5 billion in 2001, only 0.46 percent of total health spending. The two most important reasons for higher U.S. spending appear to be higher incomes and higher medical care prices.

health care sciences & services,health policy & services
Overuse and insurance plan type in a privately insured population.

Alexander J Mainor,M. Rosenthal,C. Colla,N. Morden,T. Sequist,Kevin H. Nguyen,Zhonghe Li

2018-03-01

Abstract:OBJECTIVES A substantial portion of healthcare spending is wasted on services that do not directly improve patient health and that cause harm in some cases. Features of health insurance coverage, including enrollment in high-deductible health plans (HDHPs) or health maintenance organizations (HMOs), may provide financial and nonfinancial mechanisms to potentially reduce overuse of low-value healthcare services. STUDY DESIGN Using 2009 to 2013 administrative data from 3 large commercial insurers, we examined patient characteristics and health insurance plan types associated with overuse of 6 healthcare services identified by the Choosing Wisely campaign. METHODS We explored associations between overuse and patient characteristics using multivariate logistic regression models, including patient age, gender, enrollment in an HMO, enrollment in an HDHP, an indicator of primary care fragmentation, and number of outpatient visits as explanatory variables. RESULTS Measurement of services highlighted as potential overuse by the Choosing Wisely recommendations revealed low to moderate prevalence, depending on the service. HMO coverage and enrollment in HDHPs were significantly associated with differences in prevalence of all 6 services, albeit differently in terms of the direction of the effects. Primary care fragmentation was significantly associated with higher rates of overuse. CONCLUSIONS Neither HDHPs nor HMO plans, with their closed networks and referral requirements, consistently reduced overuse, although HMO plans were never associated with higher rates of overuse. As policy makers seek levers for reducing low-value healthcare utilization, health insurance plan features may prove a valuable target, although the effect may be complicated by other factors.

Economics,Medicine
Modeling Health Care Spending Growth of Older Adults

Laura A. Hatfield,Melissa M. Favreault,Thomas G. McGuire,Michael E. Chernew

DOI: https://doi.org/10.1111/1475-6773.12640

2016-12-26

Health Services Research

Abstract:OBJECTIVE: To forecast out-of-pocket health care spending among older adults. Long-term forecasts allow policy makers to explore potential impacts of policy scenarios, but existing microsimulations do not incorporate details of supplemental insurance coverage and income effects on health care spending.DATA SOURCES: Dynamic microsimulation calibrated to survey and administrative data.STUDY DESIGN: We augment Urban Institute's Dynamic Simulation of Income Model (DYNASIM) with modules that incorporate demand responses and economic equilibria, with dynamics driven by exogenous technological change. A lengthy technical appendix provides details of the microsimulation model and economic assumptions for readers interested in applying these techniques.PRINCIPAL FINDINGS: The model projects total out-of-pocket spending (point of care plus premiums) as a share of income for adults aged 65 and older. People with lower incomes and poor health fare worse, despite protections of Medicaid. Spending rises 40 percent from 2012 to 2035 (from 10 to 14 percent of income) for the median beneficiary, but it increases from 5 to 25 percent of income for low-income beneficiaries and from 23 to 29 percent for the near poor who are in fair/poor health.CONCLUSIONS: Despite Medicare coverage, near-poor seniors will face out-of-pocket spending that would render them, in practical terms, underinsured.

health care sciences & services,health policy & services
Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

Jodi L Liu,Federico Girosi,Ruolin Lu,Christine Eibner

DOI: https://doi.org/10.1001/jamahealthforum.2024.1932

2024-06-30

JAMA Health Forum

Abstract:Importance: Households have high burden of health care payments. Alternative financing approaches could reduce this burden for some households. Objective: To estimate the distribution of household health care payments across income under health care reform policies. Design, setting, and participants: Cross-sectional study with microsimulation used nationally representative data of the US population in 2030. Civilian, noninstitutionalized population from the 2022 Current Population Survey linked to expenditures from the 2018 and 2019 Medical Expenditure Panel Survey and 2022 National Health Expenditure Accounts were included. Exposure: Rate regulation of hospital, physician, and other health care professional payments equal to the all-payer mean in the status quo, spending growth target at 4% annual per capita growth, and single-payer health care financed through taxes. Main outcomes and measures: Household health care payments (out-of-pocket expenses, premiums, and taxes) as a share of compensation. Results: The synthetic population contained 154 456 records representing 339.5 million individuals, with 51% female, 7% Asian, 14% Black, 18% Hispanic White, 56% non-Hispanic White, and 5% other races and ethnicities (American Indian or Alaskan Native only; Native Hawaiian or other Pacific Islander only; and 2 or more races). In the status quo, mean household health care payments as a share of compensation was 24% to 27% (standard error [SE], 0.2%-1.2%) across income groups (median [IQR] 22% [4%-52%] below 139% of the federal poverty level [FPL]; 21% [4%-34%] for households above 1000% FPL [11% of the population]). Under rate setting, mean (SE) payments by households above 1000% FPL increased to 29% (0.6%) (median [IQR], 22% [6%-35%]) and decreased to 23% to 25% for other income groups. Under the spending growth target, mean (SE) payments decreased from 23% to 26% (SE, 0.2%-1.2%) across income groups. Under the single-payer system, mean (SE) payments declined to 15% (0.7%) (median [IQR], 4% [0%-30%]) for those below 139% FPL and increased to 31% (0.6%) (median [IQR], 23% [3%-39%]) for those above 1000% FPL. Uninsurance fell from 9% to 6% under rate setting due to improved Medicaid access, and to zero under the single-payer system. Conclusions and relevance: Single-payer financing based on the current federal income tax schedule and a payroll tax could substantially increase progressivity of household payments by income. Rate setting led to slight increases in payments by higher-income households, who financed higher payment rates in Medicare and Medicaid. Spending growth targets reduced payments slightly for all households.
Costs and Trends in Utilization of Low-value Services Among Older Adults With Commercial Insurance or Medicare Advantage

Elizabeth A Carter,Pamela E Morin,Keith D Lind

DOI: https://doi.org/10.1097/MLR.0000000000000809

Abstract:Background: Overutilization of low-value services (unnecessary or minimally beneficial tests or procedures) has been cited as a large contributor to the high costs of health care in the United States. Objectives: To analyze trends in utilization of low-value services from 2009 to 2014 among commercial and Medicare Advantage (MA) enrollees 50 and older. Research design: A retrospective analysis of deidentified claims obtained from the OptumLab Data Warehouse. Subjects: Adults 50 and older enrolled in commercial plans and adults 65 and older enrolled in MA plans between 2009 and 2014. Measures: Costs and utilization of 16 low-value services in the following categories: cancer screening, imaging, and invasive procedures. Results: The most commonly performed low-value service was imaging of the head for syncope, at rates of 33%-39% in commercial enrollees and 45% in MA enrollees. The least common service was peripheral artery stenting (<1%) in commercial enrollees, and laminectomy (0.15% in 2009) and renal artery stenting in MA enrollees (0.07% in 2014). Renal artery stenting decreased by roughly 75% over the study period, the largest decrease in utilization, with ∼$30 million and $10 million in reduced spending for commercial and MA plans and enrollees, respectively. Spending on these services in 2014 totaled $317.6 million for commercial and $100.8 million for MA health plans. Conclusions: Clinicians, researchers, and policymakers should strive to reach consensus on methods for more reliably and accurately identifying low-value service utilization. Greater consistency would facilitate monitoring use of low-value services and changing clinical practice patterns over time.
A rare cause of recurrent abdominal pain: three familial cases with hereditary angioedema.

S. Dertlioğlu,D. Cicek,Y. Yesilova

DOI: https://doi.org/10.4103/0378-6323.104681

Indian Journal of Dermatology, Venereology and Leprology

Abstract:
Radioactivity in the Uteri of Rats Following Injection of Estrone-16-C14 ∗

I. Ringler

DOI: https://doi.org/10.3181/00379727-95-23269

1957-07-01

Abstract:Summary The partitioning of radioactivity in uterine luminal fluid and uteri from rats injected with estrone-16-C14 is described. Though a minute amount of radioactivity is present in the phenolic fraction, the major portion is present as a water soluble component. No steroidal radioactivity was present as either a conjugated or protein-bound form.
Indications and pregnancy outcomes when multidisciplinary centers for prenatal diagnosis refuse request for termination of pregnancy: a retrospective French study

M. Nguyen,H. Roman,M. Dommergues,E. Verspyck

DOI: https://doi.org/10.1002/pd.4085

2013-05-01

Prenatal Diagnosis

Abstract:To report indications and risk factors for effective termination of pregnancy (TOP) when multidisciplinary prenatal diagnosis centers refuse request for TOP.
What Drives Health-Care Spending in China? A Nationwide Decomposition Analysis

Keyang Li,Yu Qin,Guoxu Wei,Jing Wu

DOI: https://doi.org/10.1080/00036846.2022.2095346

2020-01-01

SSRN Electronic Journal

Abstract:In this study, we explore the geographic variation in health-care spending and its driving factors in China, using a nationwide and claim-level sample of inpatients ensured under the urban basic medical insurance schemes in 2010. We show geographic variation in health-care spending is substantial in China and is significantly larger than Medicare spending in the US. The substantial geographic variation is primarily driven by the quantity variation. We also discuss the potential correlates of the quantity of health care at the city level. The findings imply possible allocation inefficiency in China’s current urban health-care system.

Leg ulcer treatments: a critical review (Part 1).

Social Determinants of Health and US Health Care Expenditures by Insurer

Beyond average spending: distributional and seasonal commercial insurance trends, 2012-2021

Reducing administrative costs in US health care: Assessing single payer and its alternatives

The Effects on Hospital Utilization of the 1966 and 2014 Health Insurance Coverage Expansions in the United States

Impact of Business Operations and Policies on Healthcare Costs

Health care administration in the United States and Canada: micromanagement, macro costs

Demand Management: Enabling Patients to Use Medical Care Appropriately

Spending on and Use of Clinician-Administered Drugs in Medicare

A simple screening method for detecting isovalerylglycine in urine patients with isovaleric acidemia.

Policy Steps in the Federal Budget and Health Care to Achieve Sustainable Fiscal Conditions in the U.S.

Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits

Health Spending In The United States And The Rest Of The Industrialized World

Overuse and insurance plan type in a privately insured population.

Modeling Health Care Spending Growth of Older Adults

Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

Costs and Trends in Utilization of Low-value Services Among Older Adults With Commercial Insurance or Medicare Advantage

A rare cause of recurrent abdominal pain: three familial cases with hereditary angioedema.

Radioactivity in the Uteri of Rats Following Injection of Estrone-16-C14 ∗

Indications and pregnancy outcomes when multidisciplinary centers for prenatal diagnosis refuse request for termination of pregnancy: a retrospective French study

What Drives Health-Care Spending in China? A Nationwide Decomposition Analysis